Health TrialsbyHealthPanel

Anterior Glenoid Nerve Block Versus Pericapsular Nerve Group Block Versus Interscalene Brachial Plexus Block for Postoperative Pain Management in Shoulder Arthroscopic Surgeries

ConditionsAnterior Glenoid Nerve BlockPericapsular Nerve Group BlockInterscalene Brachial Plexus BlockPostoperative PainShoulder Arthroscopic Surgeries
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorAin Shams University

About this trial

This study aims to compare between Anterior glenoid nerve block, pericapsular nerve group (PENG) block and Interscalene brachial plexus (ISB) block for post-operative pain management in shoulder arthroscopic surgeries

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age from 18 to 70 years.

No sex predilection.

American Society of Anesthesiology (ASA) physical status I-II.

Undergoing shoulder arthroscopic surgeries.

Disqualifiers

Patient's refusal.

Patients with a history of drug allergies to study drugs.

Evidence of local infection at the site of injection.

Inability to cooperate

Trial design

Design model

Parallel

Treatments tested in this trial

  • Interscalene brachial plexus block

    Other intervention

    Patients will receive an Interscalene brachial plexus block.

  • Anterior glenoid nerve block

    Other intervention

    Patients will receive an anterior glenoid nerve block.

  • Pericapsular nerve group block

    Other intervention

    Patients will receive a pericapsular nerve group (PENG) block.

Treatment groups

49 Participants
are divided into 3 treatment groups
Group A: Interscalene brachial plexus block groupActive comparator 1 intervention
Group B: Anterior glenoid nerve block groupExperimental treatment 1 intervention
Group C: Pericapsular nerve group (PENG) block groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Time to the 1st rescue analgesia

Time to the first request for the rescue analgesia (time from the end of surgery to the first dose of pethidine administrated).

Time frame
24 hours postoperatively

Secondary outcomes

1

Total pethidine consumption

All patients will receive intravenous pethidine (30mg) on demand \[Visual Analogue Scale (VAS) score ≥3\].

Time frame
24 hours postoperatively
2

Degree of pain

Degree of pain will be assessed using visual analogue scale (VAS). Each patient will be instructed about postoperative pain assessment with the VAS. VAS (0 represents "no pain" while 10 represents "the worst pain imaginable"). VAS will be assessed at 0, 6, 12, and 24 hours postoperatively.

Time frame
24 hours postoperatively
3

Length of hospital stay

Length of hospital stay will be recorded from admission till the discharge from hospital.

Time frame
Till discharge from hospital (Up to one week).
4

Time needed for the patient to freely move the operated limb

Time needed for the patient to freely move the operated limb will be recorded.

Time frame
Postoperatively (Up to one week).

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Ain Shams University

Lead sponsor

Source ClinicalTrials.gov
Apply now